Abstract:Objection To observe the effects of monosialotetrahexosyl ganglioside sodium injection combined with citicoline in the treatment of neonatal hypoxic-ischemic encephalopathy（ NHIE）. Methods A total of 120 children with NHIE were randomly divided into control group and treatment group,with 60 cases in each group. In control group,the single-sialyl-4-hexose Ganglion sodium injection 20 mg was administered,1 time/day,intravenous drip. Treatment group was given citicoline 1 mL,1 time/day,intravenous drip on the basis of control group.The two groups were treated for 2 months. The clinical efficacy,serological indexes,scores of intelligence and motor development were compared between the two groups. Results After treatment,the total effective rate in treatment group and control group were 95. 00%,73. 33%,with significant difference（ P < 0. 05）. After treatment,the growth hormone（ GH） in treatment group and control group were（ 42. 46 ± 9. 03）,（ 27. 34 ± 8. 14） μg·L-1,soluble intercellular adhesion molecule-1（ sICAM-1） were（ 34. 58 ± 7. 52）,（ 53. 72 ± 7. 97） μg·L-1,psychomotor development index（ PDI） were 87. 51 ± 8. 24,72. 23 ± 9. 41,mental development index（ MDI） were 90. 67 ± 6. 42,77. 32 ± 6. 13,all with significant difference（ all P < 0. 05）. After treatment,the levels of adiponectin（ APN）,insulin growth factor-1（ IGF-1）,metalloproteinase-9（ MMP-9）,Tau protein（ Tau） were all with significant difference（ all P < 0. 05）.Conclusion Monosialotetrahexosyl ganglioside sodium injection combined with citicoline in the treatment of NHIE can effectively regulate the expression of serological indicators and improve the intelligence and motor development.

Clinical Trial of Monosialotetrahexosyl Ganglioside Sodium Injection Combined with Citicoline in the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy